Author

Julie Lang

University of Colorado AnschutzORCID 0000-0003-2424-8222Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Julie Lang1 paper · QIMR Berghofer Medical Research Institute

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:differential expression· 1

Frequent Co-Authors

Benjamin Guy BitleriD· 2 shared Daniel Núñez-AvellanedaiD· 2 shared Elizabeth R. WoodruffiD· 2 shared Fabian R. VillagómeziD· 2 shared Margaret Cobb NevilleiD· 2 shared Patricia G. WebbiD· 2 shared Brianna AmesiD· 1 shared Fredrick Joseph RosarioiD· 1 shared

Activity by Year

2024-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Benjamin Guy BitlerORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Pharmacology & ToxicologybioRxivPreprintMay 12, 2026

Nephrotoxicity of Immune Checkpoint Inhibitors in Mice with a Human Immune System

Sarah C. Asby, Xia Wen, Michael J. Goedken…·Melanie S. Joy

This study investigates ICI-related kidney injury in a humanized mouse model, identifying immune biomarkers and mechanisms of nephrotoxicity.

DOI 10.64898/2026.05.07.723340

mousebulk RNA-seq

𝕏 PostBluesky

Cancer BiologyCancer Research CommunicationsPeer-reviewedDec 3, 2024

Claudin-4 remodeling of nucleus-cell cycle crosstalk maintains ovarian tumor genome stability and drives resistance to genomic instability-inducing agents.

Fabian R. Villagómez, Julie Lang, Daniel Núñez-Avellaneda…·Benjamin Guy Bitler

This paper shows that claudin-4 remodels nucleus-cell cycle interactions to maintain genome stability and resist genomic instability-inducing agents in ovarian cancer.

6 citations

humanexperimental assay

𝕏 PostBluesky

Cancer BiologyCancer Research CommunicationsPeer-reviewedJun 13, 2024

Claudin-4 modulates autophagy via SLC1A5/LAT1 as a tolerance mechanism for genomic instability in ovarian cancer.

Fabian R. Villagómez, Julie Lang, Fredrick Joseph Rosario…·Benjamin Guy Bitler

This study shows claudin-4 promotes genomic instability tolerance in ovarian cancer by linking cell junctions to autophagy via SLC1A5/LAT1, and targeting it enhances PARPi efficacy.

10 citations

humanproteomics

𝕏 PostBluesky